Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2019 Jul 1;81(3):345–354. doi: 10.1097/QAI.0000000000002043

Table 1.

Demographic and clinical characteristics of participants

Demographic Variables HIV− controls HIV+ p value
n = 53 56
BACKGROUND DEMOGRAPHICS
Sex (Men/Women) 29/24 40/16 ns
Age 47.8 ± 13.2 52.5 ± 7.9 .03 [HIV+ > HIV−]
Education (years) 15.7 ± 2.5 13.7 ± 2.5 <.001 [HIV+ < HIV−]
Hepatitis C (%) 0% 29.1% /
Beck Depression Inventory-II (BDI-II) Score * 2.4 ± 3.5; 1.0 9.8 ± 8.4; 8.5 <.001 [HIV+ > HIV−]
HIV-RELATED DEMOGRAPHICS
HIV Approx. Age of Onset / 35.9 ± 9.5 /
Length of time with HIV (years) / 16.6 ± 8.2 /
Log Viral Load (n = 51) / 2.1 ± 1.1 /
CD4 Count* (n = 54) / 611.3 ± 286.0; 571.0 /
AIDS Status (%) (n = 55) / 50.9% /
HAART Medications (%) (n = 55) / 90.9% /
*

Mean ± SD; median

ns=not significant